Elsevier Is Re-Launching "Embase" To Be A Powerful Resource Providing Deep Insights And Answers To Biomedical Researchers
Amsterdam, 30 November 2009 - Elsevier, the world’s leading publisher of scientific, medical and technical products and services, today announced a major re-launch of Embase, its comprehensive biomedical database which holds over 20 million indexed records from more than 7,000 active, peer reviewed journals.
Embase has long played a key role in the advancement of new biomedical and pharmaceutical insights. Now, new developments and updates include:
• Enabling all biomedical researchers to use Embase -- extending its “usability” from information specialists to also include all biomedical and pharmaceutical scientists, and clinical and regulatory professionals.
• New retrieval tools that further drive discovery, including quick and easy refining of search results and the display of indexed drug-drug and drug-disease relations.
• Improved comprehensiveness through the addition of indexed articles-in-press and conference abstracts.
• To signify the enhanced focus on biomedical answers, the product has a new, fresh look and feel to it.
Thomas Gutjahr, Head of the Knowledge Center at Actelion Pharmaceuticals Ltd., comments: “I’m very impressed by all the new improvements which I believe will greatly help with pin-pointing certain searches, e.g. drug-drug interactions or drug-disease searches.”
Embase supports researchers with key tasks such as tracking of drug adverse events, comparing drug therapies, and Evidence Based Medicine research. It provides researchers with deep insights and understanding from the world’s life sciences information, enabling effective discoveries towards medical discovery and treatment.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 38,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com